These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension. Li DP, Pan HL. Hypertension; 2007 Apr 15; 49(4):916-25. PubMed ID: 17309953 [Abstract] [Full Text] [Related]
29. Effects of mu-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses. Kiritsy-Roy JA, Appel NM, Bobbitt FG, Van Loon GR. J Pharmacol Exp Ther; 1986 Dec 15; 239(3):814-22. PubMed ID: 3025420 [Abstract] [Full Text] [Related]
33. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. Ciccocioppo R, Fedeli A, Economidou D, Policani F, Weiss F, Massi M. J Neurosci; 2003 Oct 15; 23(28):9445-51. PubMed ID: 14561874 [Abstract] [Full Text] [Related]
34. Haemodynamic and renal sympathetic responses to V1b vasopressin receptor activation within the paraventricular nucleus. El-Werfali W, Toomasian C, Maliszewska-Scislo M, Li C, Rossi NF. Exp Physiol; 2015 Apr 20; 100(5):553-65. PubMed ID: 25605313 [Abstract] [Full Text] [Related]
40. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G. Peptides; 2007 Jun 20; 28(6):1240-51. PubMed ID: 17532097 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]